BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/14/2020 8:10:05 AM | Browse: 668 | Download: 1029
 |
Received |
|
2020-10-11 22:23 |
|
Peer-Review Started |
|
2020-10-11 22:23 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-11-03 14:09 |
|
Revised |
|
2020-11-06 10:28 |
|
Second Decision |
|
2020-11-20 09:26 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2020-11-21 05:34 |
|
Articles in Press |
|
2020-11-21 05:34 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2020-11-24 03:10 |
|
Typeset the Manuscript |
|
2020-12-07 00:51 |
|
Publish the Manuscript Online |
|
2020-12-14 08:10 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Challenges in COVID-19 drug treatment in patients with advanced liver diseases: A hepatology perspective
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Amr Shaaban Hanafy and Sherief Abd-Elsalam |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Sherief Abd-Elsalam, MD, PhD, Assistant Professor, Tropical Medicine, Tanta University, Elbahr Street, Tanta 35127, Egypt. sherif.abdelbaky@med.tanta.edu.eg |
| Key Words |
Cirrhosis; COVID-19; Drugs; Advanced liver disease; Anticoagulation; Coagulopathy |
| Core Tip |
The coronavirus disease 2019 panademic put the health care systems of many countries under great pressure and challenges with lack of prediction parameters and effective pharmacotherapies still under trials and we provided a stepwise approach to treat coronavirus disease 2019 in advanced liver disease hoping to applied in a multicenter approach. |
| Publish Date |
2020-12-14 08:10 |
| Citation |
Hanafy AS, Abd-Elsalam S. Challenges in COVID-19 drug treatment in patients with advanced liver diseases: A hepatology perspective. World J Gastroenterol 2020; 26(46): 7272-7286 |
| URL |
https://www.wjgnet.com/1007-9327/full/v26/i46/7272.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v26.i46.7272 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
